William Tansey
-
Promising drug-like compounds found to have strong action against blood cancers
Research from the lab of Bill Tansey and other collaborators tested protein inhibitors called WINi against a panel of cancer cells and found that they have strong action against blood cancers and synergize with an FDA-approved cancer drug. Read MoreSep 5, 2024
-
Class of 2021: Interdisciplinary teamwork in the lab leads Ph.D. student to job with biotech giant
After graduating with a Ph.D. in cell and developmental biology from the Vanderbilt School of Medicine Basic Sciences, Alissa Guarnaccia will begin a rare postdoctoral research position with health care biotechnology giant Genentech. Read MoreApr 9, 2021
-
A protein that can melt tumors discovered at Vanderbilt
For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. Read MoreJan 27, 2021
-
WIN for blocking cancer growth
William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth. Read MoreJan 21, 2021
-
Protein research seeks to induce tumor regression
MYC is a family of three related proteins that are overexpressed in cancer and which contribute to an estimated 100,000 cancer deaths annually in the United States. Understanding how MYC works could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks. Read MoreJan 29, 2020
-
Sweatt, Tansey discuss influence of epigenetics on research
Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks. Read MoreNov 2, 2017
-
Vanderbilt’s Sweatt, Tansey set for next Discovery Lecture
How epigenetic regulation of gene transcription forms new memories and triggers cancerous growth is the subject of the next Vanderbilt Discovery Lecture on Oct. 26. Read MoreOct 19, 2017
-
VICC Annual Scientific Retreat slated for May 4
Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center Annual Scientific Retreat, to be held Thursday, May 4. Read MoreApr 27, 2017
-
Lemonade Stand grant boosts Tansey’s pediatric tumor research
William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs). Read MoreSep 1, 2016
-
‘Docking stations’ on chromosomes new anti-cancer target
Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks. Read MoreMar 26, 2015
-
Record number elected AAAS fellows
Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read MoreNov 29, 2012